Medpace Holdings, Inc. has grown revenue 18% a year over three years and 22% a year over five, with earnings per share compounding at 27%. Revenue growth, 3-year annual rate: +18% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +22%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +27%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 11, FY2015 to FY2025, as filed.

MEDPMedpace Holdings, Inc.

HealthcareUSD

$619.99

$393.4252 weeks$620.70

Is it growing?

Is MEDP growing?

Medpace Holdings, Inc. has grown revenue 18% a year over three years and 22% a year over five, with earnings per share compounding at 27%.

+18%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +22%
Revenue growth, 5-year rate · +18% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +27%
Earnings per share, 3-year rate · revenue +18% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 11
Years of annual history on file · FY2015 to FY2025, as filed